Results 131 to 140 of about 23,403 (218)

Clinical Pharmacology of Loop Diuretics in Critical Care. [PDF]

Clin Pharmacokinet
Ferrari F, Zanza C, Tesauro M, Longhitano Y, Planinsic R, Voza A, Fumagalli J, Scaravilli V, Grasselli G.   +8 more
europepmc   +1 more source

Continuous Infusion Versus Bolus Injection of Loop Diuretics for Patients With Congestive Heart Failure: A Meta-Analysis. [PDF]

Cureus, 2023
Karedath J, Asif A, Tentu N, Zahra T, Batool S, Sathish M, Sandhu QI, Khan A.   +7 more
europepmc   +1 more source

Empagliflozin Versus Dapagliflozin and Urogenital Adverse Events in Type 2 Diabetes: A Target Trial Emulation

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7367-7379, August 2026.
ABSTRACT Aims Urogenital adverse events are common with sodium‐glucose co‐transporter 2 inhibitors (SGLT2i) and may influence treatment decisions. Variations in SGLT2i selectivity, potency and effects on renal glucose excretion could lead to differences in safety profiles. We compared the risks of urinary tract infection (UTI), genital tract infection (
Christine Ljungberg, Kasper Bonnesen, Morten Schmidt, Christina Vandenbroucke‐Grauls, Michael Dalager‐Pedersen, Henrik Toft Sørensen, Mette Nørgaard, Reimar Wernich Thomsen   +7 more
wiley   +1 more source

Impact of Loop Diuretics on Long-Term Kidney Outcome: A Post Hoc Analysis of the STOP-Angiotensin-Converting Enzyme Inhibitor Trial. [PDF]

Kidney360
Bhandari S, Mehta S, Ives N, Cleland JGF, Cockwell P.   +4 more
europepmc   +1 more source

Characterization of Usage Patterns of Drugs Suspected to Cause Adverse Drug Reactions in Older Hospitalized Patients

Geriatrics &Gerontology International, Volume 26, Issue 8, August 2026.
ABSTRACT Aim This study aimed to characterize the usage patterns of drugs suspected to cause adverse drug reactions (ADRs) in older hospitalized patients. Methods Medical records of older adults admitted to the Department of Geriatrics and Hypertension at Osaka University Hospital from September 2014 to August 2021 were reviewed.
Mizuki Katsuhisa, Shota Hamada, Chie Hamaie, Yuko Takeshita, Kasumi Ikuta, Yuichiro Saizen, Eriko Koujiya, Yoichi Takami, Koichi Yamamoto, Yasushi Takeya   +9 more
wiley   +1 more source

Determinants of diuresis/natriuresis following ambulatory intravenous loop diuretics for worsening heart failure. [PDF]

ESC Heart Fail
Massin M, Baudry G, Duarte K, Monzo L, Sadoul N, Caspi O, Mullens W, Huttin O, Girerd N.   +8 more
europepmc   +1 more source

Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization. [PDF]

ESC Heart Fail, 2022
Imaeda S, Shiraishi Y, Kohsaka S, Niimi N, Goda A, Nagatomo Y, Takei M, Saji M, Nakano S, Kohno T, Fukuda K, Yoshikawa T.   +11 more
europepmc   +1 more source

Association Between Reduction in Loop Diuretics and Heart Failure Rehospitalization After Transcatheter Aortic Valve Replacement. [PDF]

Circ Rep
Takegawa K, Kanaoka K, Iwanaga Y, Sasano T, Nishioka Y, Myojin T, Noda T, Imamura T, Miyamoto Y.   +8 more
europepmc   +1 more source

Hypokalemia-Induced Rhabdomyolysis Following Prolonged Diarrhea in a Child With Congenital Heart Disease Receiving Loop Diuretics: A Case Report and Literature Review. [PDF]

Cureus
Iwasaki K, Akiyoshi M, Nakashima S, Yasuda K, Taketani T.   +4 more
europepmc   +1 more source

Amiodarone‐related thyroid dysfunction and associated outcomes in patients with heart failure—A nationwide cohort study

Journal of Internal Medicine, Volume 300, Issue 2, Page 204-212, August 2026.
Abstract Aim Amiodarone increases the risk of thyroid dysfunction, but the prognostic significance of this complication in patients with heart failure (HF) is uncertain. This study investigates the association between amiodarone‐related thyroid dysfunction and risk of HF hospitalization or death in a nationwide cohort.
Søren Lund Kristensen, Sam Aiyad Ali, Mads Ersbøll, Jawad Haider Butt, Rasmus Rørth, Lucas Malta Westergaard, Lauge Østergaard, Finn Gustafsson, Oren Caspi, Emil Fosbøl, Lars Køber, Christian Selmer   +11 more
wiley   +1 more source